Results were announced from a phase 3 study evaluating an investigational intramuscular (IM) formulation of ibalizumab-uiyk for the treatment of heavily treatment-experienced adults with ...
The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...
Biocon Biologics has made strides in the healthcare sector by obtaining Health Canada’s approval for Yesintek and Yesintek IV ...
Capital Market on MSN
Biocon's biologics arm gets Health Canada approval for monoclonal antibody drug Yesintek
Yesintek is ustekinumab injection and Yesintek I.V. is ustekinumab for injection, solution for intravenous infusion. These ...
Please provide your email address to receive an email when new articles are posted on . Stemedica Cell Technologies announced the launch of a phase 2b/3 clinical trial to assess the safety, efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback